|
www.PicksThatMove.com: "Picks that move" Alerts, August 6, 2009: SPPI, ARQL, SMSC, CONN, AMCS and ALTI.
(M2 PressWIRE Via Acquire Media NewsEdge) Picksthatmove.com Alerts include Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI); ArQule, Inc. (NASDAQ: ARQL); SMSC (NASDAQ: SMSC); Conn's, Inc. (NASDAQ/NM: CONN); AMICAS, Inc. (Nasdaq: AMCS) and Altair Nanotechnologies, Inc. (NASDAQ: ALTI)
-- August 6, 2009 Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI) trading at $6.65 on a volume of 1.12M shares.
In a press release out on August 6, 2009 Spectrum Pharmaceuticals Acquires Full Rights and Intellectual Property for RenaZorb(R) for All Fields of Use
RenaZorb, a Novel Compound, is Being Developed for Chronic Kidney Disease
IRVINE, Calif., Aug 06, 2009 -- Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has acquired 100% rights to RenaZorb(R) (a family of compounds represented by SPI-014, also known as RZB-014), a lanthanum-based nanotechnology compound with potent and selective phosphate binding properties, for all human and non-human indications.
About Spectrum Pharmaceuticals
Spectrum Pharmaceuticals is a commercial-stage biotechnology company with a focus in oncology. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy. For more information, please visit our website at www.spectrumpharm.com.
-- August 6, 2009 ArQule, Inc. (NASDAQ: ARQL) trading at $5.50 on a volume of 22,484 shares
In a press release on August 6, 2009 ArQule Reports Second Quarter 2009 Financial Results
WOBURN, Mass., Aug 06, 2009 -- ArQule, Inc. (NASDAQ: ARQL) today announced its financial results for the second quarter of 2009.
For the quarter ended June 30, 2009, the Company reported a net loss of $8,272,000 or $0.19 per share, compared with a net loss of $16,040,000, or $0.37 per share, for the second quarter of 2008. For the six-month period ended June 30, 2009, the Company reported a net loss of $18,180,000 or $0.41 per share, compared to a net loss of $29,954,000, or $0.68 per share, for the six-month period ended June 30, 2008.
About ArQule
ArQule is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead product, in Phase 2 clinical development, is ARQ 197, an inhibitor of the c-MET receptor tyrosine kinase. The Company has also initiated Phase 1 clinical testing with ARQ 621, designed to inhibit the Eg5 kinesin motor protein. An additional clinical-stage program includes compounds that activate the cell's DNA damage response mechanism mediated by the E2F-1 transcription factor. The Company's pre-clinical pipeline includes a compound designed to inhibit the BRAF kinase. ArQule's current discovery efforts, which are based on the ArQule Kinase Inhibitor Platform (AKIP(TM)) are focused on the identification of novel kinase inhibitors that are potent, selective and do not compete with ATP (adenosine triphosphate) for binding to the kinase.
-- August 6, 2009 SMSC (NASDAQ:SMSC) trading at $22.80 on a volume of 74,105 shares.
In a press release out on August 6, 2009 SMSC Reduces Power Consumption of Automotive Infotainment with Delivery of a Single-Chip Power Management Solution for MOST(R) Network Devices
HAUPPAUGE, N.Y., Aug 06, 2009 -- SMSC (NASDAQ:SMSC), a leading semiconductor company that provides Smart Mixed-Signal Connectivity(TM) solutions, today announced the MPM85000, a low-cost, single-chip solution for power management of Media Oriented Systems Transport (MOST(R)) devices. Seeing the need to eliminate several discrete electronic components, SMSC's MPM85000 combines all necessary peripheral functions to implement a MOST network interface such as diagnostics, status monitoring and power supply.
About SMSC's Automotive Product Line
SMSC's Automotive Information Systems is a supplier of TrueAuto(TM) infotainment and information semiconductor solutions to major automakers, including Audi, BMW, Daimler, Hyundai/Kia, Jaguar, Land Rover, Porsche, Toyota and Volvo. SMSC is a founding member of the MOST Cooperation, a cooperative of automakers, automotive systems architects and manufacturers and key components suppliers working to extend and refine the MOST(R) standard for the evolving requirements of automotive multimedia networking. Additional information is available at www.smsc-ais.com.
-- August 6, 2009 Conn's, Inc. (NASDAQ/NM: CONN) trading at $13.57 on a volume of 55,374 shares.
In a press release out on August 6, 2009 Conn's, Inc. Reports Net Sales Results for the Quarter Ended July 31, 2009
BEAUMONT, Texas, Aug 06, 2009 -- Conn's, Inc. (NASDAQ/NM: CONN), a specialty retailer of consumer electronics, home appliances, furniture, mattresses, computers and lawn and garden products, today announced its net sales results for the quarter ended July 31, 2009.
About Conn's, Inc.
The Company is a specialty retailer currently operating 75 retail locations in Texas, Louisiana and Oklahoma: with 23 stores in the Houston area, 19 in the Dallas/Fort Worth Metroplex, nine in San Antonio, five in Austin, five in Southeast Texas, one in Corpus Christi, four in South Texas, six in Louisiana and three in Oklahoma. It sells home appliances, including refrigerators, freezers, washers, dryers, dishwashers and ranges, and a variety of consumer electronics, including LCD, LED, plasma and DLP televisions, camcorders, digital cameras, computers and computer accessories, Blu-ray and DVD players, video game equipment, portable audio, MP3 players, GPS devices and home theater products. The Company also sells lawn and garden products, furniture and mattresses, and continues to introduce additional product categories for the home to help respond to its customers' product needs and to increase same store sales. Unlike many of its competitors, the Company provides flexible in-house credit options for its customers. In the last three years, the Company financed, on average, approximately 61% of its retail sales.
-- August 6, 2009 AMICAS, Inc. (Nasdaq: AMCS) trading at $13.57 on a volume of 55,374 shares.
In a press release out on August 6, 2009 AMICAS Schedules Second Quarter 2009 Earnings Results Conference Call
BOSTON, July 23, 2009 -- AMICAS, Inc. (Nasdaq: AMCS), a leader in image and information management solutions, today announced it will report the company's financial results for the second quarter ending June 30, 2009, after the market closes on Wednesday, August 5, 2009.
About AMICAS
AMICAS, Inc. (www.amicas.com) is a leading independent provider of imaging IT solutions. AMICAS offers the industry's most comprehensive suite of image and information management solutions - from radiology PACS to cardiology PACS, from radiology information systems to cardiovascular information systems, from revenue cycle management solutions to enterprise content management tools designed to power the imaging component of the electronic medical record (EMR). AMICAS provides a complete, end-to-end solution for radiology practices, imaging centers, and ambulatory care facilities. Hospitals and integrated delivery networks are provided with a comprehensive image management solution for cardiology and radiology that supports EMR strategies to enhance clinical, operational, and administrative functions.
-- August 6, 2009 Altair Nanotechnologies, Inc. (NASDAQ: ALTI) trading at $0.95 on a volume of 696,840 shares
In a press release out on August 6, 2009 Altairnano to Provide Proterra With Battery Modules for Electric Buses
RENO, NV, Aug 06, 2009 -- Altair Nanotechnologies, Inc. (Altairnano) (NASDAQ: ALTI), a leading provider of energy storage systems for clean, efficient power and energy management, today announced it has been selected by Proterra, a leading manufacturer of zero emission commercial transportation solutions, to deliver advanced battery modules for electric buses. The value of the contract is $898,400.
About Altair Nanotechnologies, Inc.
Headquartered in Reno, Nevada with manufacturing in Anderson, Indiana, Altairnano is a leading provider of energy storage systems for clean, efficient power and energy management. Going beyond lithium ion, Altairnano's Lithium-Titanate based battery systems are among the highest performing and most scalable, with applications that include battery cells for military artillery, battery packs for hybrid vehicles and energy storage systems for large-scale stationary power services. For more information please visit Altairnano atwww.altairnano.com.
About PicksThatMove.com
www.picksthatmove.com team of excellence strives to find undervalued, good momentum stock plays. We provide financial and investor relations services for small to mid-cap stocks with weekly and special newsletters to keep you informed of the latest movers. Unlike other sites, we explore, research, and understand all aspects of a company. We only recommend companies we feel has the potential for future higher valuations. Our seasoned research team is always looking for the next Xtreme Pick to send to you.
www.picksthatmove.com is a leading stock website that provides free daily alerts on stocks that are moving up. www.picksthatmove.com also tracks small cap stocks that are on the brink of exploding. We also feature companies on our website with research report, analysis, and newsletters. To feature a company on our web site please contact us at Info@picksthatmove.com
www.picksthatmove.com is an independent electronic publication that provides information on selected publicly traded companies. www.picksthatmove.com is not a registered investment advisor or broker-dealer. www.picksthatmove.com affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS
[ Back To Homepage ]
|
Home
Featured Article Archives
eNews
RSS FEED
